These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 318211)

  • 41. Activities of cefoxitin in vitro and in vivo: a study in patients with biliary tract infection undergoing percutaneous transhepatic biliary drainage.
    Masuda G; Tabata I; Isawa T; Yamazaki E; Mizuoka K
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):367-72. PubMed ID: 3526054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasmid-related resistance to cefoxitin in species of the Bacteroides fragilis group isolated from intestinal tracts of calves.
    dos Santos Almeida F; Avila-Campos MJ
    Curr Microbiol; 2006 Nov; 53(5):440-3. PubMed ID: 17019644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.
    Kosmidis J; Hamilton-Miller JM; Gilchrist JN; Kerry DW; Brumfitt W
    Br Med J; 1973 Dec; 4(5893):653-5. PubMed ID: 4202265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prophylaxis of and therapy for polymicrobial infection in mice with cefoxitin, cefotetan, and cefmetazole.
    Brook I
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S425-6. PubMed ID: 8324161
    [No Abstract]   [Full Text] [Related]  

  • 45. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.
    Snydman DR; McDermott L; Cuchural GJ; Hecht DW; Iannini PB; Harrell LJ; Jenkins SG; O'Keefe JP; Pierson CL; Rihs JD; Yu VL; Finegold SM; Gorbach SL
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S54-65. PubMed ID: 8953108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacteroides fragilis group: trends in resistance.
    Fille M; Mango M; Lechner M; Schaumann R
    Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-antibiotic effect in Bacteroides fragilis group.
    Siverhus DJ; Edmiston CE; Clausz JC; Goheen MP
    Ann Clin Lab Sci; 1988; 18(4):326-36. PubMed ID: 3165611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of antibiotic activities by using serum bactericidal activity over time.
    Guglielmo BJ; Rodondi LC
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1511-4. PubMed ID: 3056237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Study of the minimum inhibiting concentration of a new cephalosporin (HR 756): comparative data with other beta-lactamic antibiotics].
    Mascellino MT; Prignano G; Iegri F; Delia S
    Boll Ist Sieroter Milan; 1981 May; 60(2):102-9. PubMed ID: 6272823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bactericidal activity of chloramphenicol, clindamycin, metronidazole and cefoxitin against Bacteroides fragilis.
    Soriano F; Ponte M; García-Hierro P
    J Antimicrob Chemother; 1980 Sep; 6(5):679-80. PubMed ID: 7410288
    [No Abstract]   [Full Text] [Related]  

  • 55. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
    Wells CL; Arland LA; Simmons RL; Rotstein OD
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Susceptibility of clinical isolates of Bacteroides fragilis group strains to cefoxitin, cefoperazone and ticarcillin/clavulanate.
    Peixoto Júnior AA; Rocha MM; Moreira JL; Carvalho CB
    Rev Inst Med Trop Sao Paulo; 2000; 42(3):137-9. PubMed ID: 10887372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of the in vitro activity of cefoxitin and cephalothin against 7,312 clinical isolates.
    Lingaas E; Midtvedt T; Melby K; Dahl OU
    Chemotherapy; 1981; 27(4):239-46. PubMed ID: 7249786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents.
    Aldridge KE; Henderberg A; Sanders CV
    J Antimicrob Chemother; 1990 Sep; 26(3):353-9. PubMed ID: 2228826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
    Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
    Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative studies of cefoxitin and cephalothin: an overview.
    Neu HC
    Rev Infect Dis; 1979; 1(1):144-51. PubMed ID: 400931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.